Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody-Reference-Cited by-同舟云学术

Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody

Published:2014-12 Issue:3 Volume:44 Page:331-337
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Guillen-Del Castillo Alfredo^ORCID,Pilar Simeón-Aznar Carmen,Fonollosa-Pla Vicent,Alonso-Vila Serafín,Reverte-Vinaixa María M.,Muñoz Xavier,Pallisa Esther,Selva-O׳Callaghan Albert,Fernández-Codina Andreu,Vilardell-Tarrés Miquel

Funder

Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference43 articles.

1. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status;Simeon-Aznar;Semin Arthritis Rheum,2012

2. Severe restrictive lung disease in systemic sclerosis;Steen;Arthritis Rheum,1994

3. African–American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease;Greidinger;Chest,1998

4. Mortality in systemic sclerosis: an international meta-analysis of individual patient data;Ioannidis;Am J Med,2005

5. Autoantibodies in systemic sclerosis;Steen;Semin Arthritis Rheum,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2024-08

2. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11

3. Unusual presentation of antisynthetase syndrome: a case series and review of the literature;Journal of Medical Case Reports;2023-07-30

4. Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms;Biomedicines;2023-07-26

5. Systemic Sclerosis-Associated Myopathy: How to Treat;Current Treatment Options in Rheumatology;2023-07-19